Lv714
3750 积分 2023-10-08 加入
Modified adriamycin‐vincristine‐dexamethasone (m‐VAD) in primary refractory and relapsed plasma cell myeloma: an NCI (Canada) pilot study
16天前
已完结
Pharmacokinetics of intraventricular and intravenous N,N',N''-triethylenethiophosphoramide (thiotepa) in rhesus monkeys and humans
30天前
已关闭
Chemistry, pharmacology and pharmacokinetics of N,N′,N′′ -triethylenethiophosphoramide (ThioTEPA)
30天前
已完结
Targeting immune checkpoints in lymphoma
1个月前
已完结
Novel Immunologic Approaches in Lymphoma: Unleashing the Brakes on the Immune System
1个月前
已完结
Where Do Programmed Death-1 Inhibitors Fit in the Management of Malignant Lymphoma?
1个月前
已完结
Checkpoint Inhibitors Hodgkin Lymphoma and Non-Hodgkin Lymphoma
1个月前
已完结
Rising to the Top: How Immune-Checkpoint Inhibitors are Changing the Landscape of Treatment for Classic Hodgkin Lymphoma
1个月前
已完结
Immune checkpoints in B-cell Lymphoma: Still an Unmet challenge from Basic research to clinical practice
1个月前
已完结
Current challenges of hematologic complications due to immune checkpoint blockade: a comprehensive review
1个月前
已完结
皖公网安备34019202002308
